1Department of Molecular Genetics and Cell Biology, The University of Chicago, Illinois 60637, USA. bs19@midway.uchicago.edu
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Tumor suppressor TP53 shows increased mutation rates during cancer development. Analysis of silent and multiple mutations suggests TP53 is hypermutable at certain stages of tumorigenesis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: